Tanio Y, Watanabe M, Inoue T, Kawase I, Shiraska T, Ikeda T, Hara H, Masuno T, Saito S, Kawano K
Third Department of Internal Medicine, Osaka University Medical School.
Jpn J Cancer Res. 1990 Mar;81(3):289-97. doi: 10.1111/j.1349-7006.1990.tb02563.x.
New cell lines of small cell lung cancer (SCLC) were established from specimens of untreated primary tumors biopsied by diagnostic bronchofiberscopy. The advantage of this method was ease of obtaining specimens from lung tumors. Establishment of cell lines was successful with 4 of 13 specimens (30%). Clinical responses of the tumors showed considerable variation, but were well correlated with the in vitro sensitivity of the respective cell lines to chemotherapeutic drugs and irradiation. One of the cell lines was resistant to all drugs tested and irradiation, while another was sensitive to all of them. Although the acquired resistance of SCLC is the biggest problem in treatment, the natural resistance to therapy is another significant problem. Either acquired or natural, resistance mechanisms of SCLC may be elucidated by the use of such cell lines derived from untreated tumors. This method and these SCLC cell lines are expected to be useful for the serial study of biologic and genetic changes of untreated and pre-treated tumors, or primary and secondary tumors.
从小细胞肺癌(SCLC)未经治疗的原发性肿瘤标本中,通过诊断性支气管纤维镜活检建立了新的细胞系。该方法的优点是易于从肺肿瘤获取标本。13个标本中有4个(30%)成功建立了细胞系。肿瘤的临床反应显示出相当大的差异,但与各个细胞系对化疗药物和放疗的体外敏感性密切相关。其中一个细胞系对所有测试药物和放疗均耐药,而另一个则对所有药物和放疗敏感。尽管小细胞肺癌获得性耐药是治疗中最大的问题,但对治疗的天然耐药也是另一个重要问题。无论是获得性还是天然的,小细胞肺癌的耐药机制都可以通过使用源自未经治疗肿瘤的此类细胞系来阐明。这种方法和这些小细胞肺癌细胞系有望用于对未经治疗和预处理肿瘤或原发性和继发性肿瘤的生物学和基因变化进行系列研究。